Thursday, July 11, 2013 1:18:53 PM
All opinions on this board are welcomed and should be encouraged. The fact is that there are many fundamentalists (suck as myself) and many Chartists, all of whom offer excellent insight into the price action and macro picture of the company and related SP action. The Chartists here have offered estimates of picot points and well as conditional support/resistance levels based on commonly utilized technical indicators. This is concrete and indicative of significant contribution to the betterment of the board and should not be discouraged. It is not dangerous, it is educational, and like any other post should be vetted to help in making decisions regarding adjusting entry and exit levels accordingly. As long as there is no pumping nor bashing, thank you to all who contribute.
Recent DSS News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 08:53:21 PM
- DSS, Inc. Letter to Shareholders • GlobeNewswire Inc. • 04/15/2026 08:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 09:00:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:30:59 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/17/2026 09:30:13 PM
- Form PRER14C - Information statements • Edgar (US Regulatory) • 02/06/2026 08:19:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 10:06:08 PM
- DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 02/05/2026 02:45:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/05/2026 12:46:51 PM
- DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 02/04/2026 01:35:00 PM
- DSS, Inc. Announces Launch of Proposed Public Offering • GlobeNewswire Inc. • 02/04/2026 01:17:01 AM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 01/14/2026 09:30:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:25:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 08:48:41 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 10/21/2025 06:04:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/20/2025 01:47:13 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/03/2025 01:50:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2025 01:43:10 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2025 08:13:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 08:53:38 PM
- DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger • GlobeNewswire Inc. • 06/24/2025 12:30:00 PM
- DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth • GlobeNewswire Inc. • 05/22/2025 12:31:00 PM
